CJC-1295 (No DAC) 10 mg Certificate of Analysis Batch APL-CJC10-2606-01

CJC-1295 (No DAC) 10 mg from batch APL-CJC10-2606-01 was analysed on 19 June 2026 and measured 98.52% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity: 98.52%
Result: All 5 tests passed
Tested: 19 June 2026
Method: HPLC / Mass Spectrometry
Net content: 10.16 mg

Independent verification

CJC-1295 (No DAC) 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.48% purity by UPLC-MS/MS, analysed 28 August 2026 on lot APL-CJC5-2608-01, net content 4.88 mg, verification code OZ-HPLCMS-TS04; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 30 August 2026, verification code OZ-ENDOTX-TAU1.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Third-Party Purity COA (PDF, opens in a new tab)99.48% purity by UPLC-MS/MS · net content 4.88 mg Analysed 28 August 2026 Verification code OZ-HPLCMS-TS04
Third-Party Endotoxin Test (PDF, opens in a new tab)Bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL Analysed 30 August 2026 Verification code OZ-ENDOTX-TAU1

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis CJC-1295 (No DAC) 10 mg Batch APL-CJC10-2606-01

Compound: CJC-1295 (No DAC)
Lot Number: APL-CJC10-2606-01
Analysis Date: 19 June 2026
Method: HPLC / Mass Spectrometry
Purity: 98.52%
Net Content: 10.16 mg

Formula: C152H252N44O42
Molecular Weight: 3367 g/mol
Form: Lyophilised Powder
Manufactured: June 2026
Issued: 20 June 2026
Document ID: APL-COA-CJC10-2606-01
Verification Code: Batch traceable

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

Main peak integrated at 98.52% of total area; no single impurity peak exceeds 0.62%.

Peak List

Peaks detected: 5

#	Time (min)	Area	% Area	Identification
1	3.742	31,001	0.380	—
2	3.976	51,226	0.620	—
3	4.107	8,114,457	98.520	CJC-1295 (No DAC)
4	4.596	22,277	0.270	—
5	5.734	17,169	0.210	—

Analytical Results

Test	Specification	Result	Status
Appearance	White/Off-White Lyophilised Powder	Conforms	PASS
Identity (MS)	Confirmed	Confirmed	PASS
Purity (HPLC)	≥98.0%	98.52%	PASS
Peptide Content	95–105%	99.2%	PASS
Endotoxins	<0.5 EU/mg	<0.25 EU/mg	PASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

CJC-1295 (No DAC) 10 mg

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 June 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
674	674.39	1.55
843	842.74	3.71
1123	1123.34	1.24

Detection assignment: CJC-1295 (No DAC)

Collected Mass Spectrum

Intensity ×10⁷

Verification Protocol

Identity confirmed by mass spectrometry against the expected ion channels.
Purity measured by HPLC as peak area against all integrated impurity peaks.
Batch traceability: this document reports the lot number printed on the vial.
Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View CJC-1295 (No DAC) in the catalogue How to read this certificate